Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BanColombia S.A.

46.5% sales growth and 3.58% return on equity

Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala.

BanColombia S.A.’s sales growth this year is anticipated to be 13.6% and 5.1% for next year.

Year-on-year quarterly revenue growth declined by 30.4%, now sitting on N/A for the twelve trailing months.

BanColombia S.A.’s sales growth for the next quarter is 46.5%. The company’s growth estimates for the current quarter and the next is a negative 68.4% and 2.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.58%.

Volatility

BanColombia S.A.’s last day, last week, and last month’s average volatility was a negative 1.39%, a negative 0.62%, and a positive 0.56%, respectively.

BanColombia S.A.’s last day, last week, and last month’s high and low average amplitude percentage was 3.48%, 2.76%, and 3.09%, respectively.

BanColombia S.A.’s Stock Yearly Top and Bottom Value

BanColombia S.A.’s stock is valued at $39.71 at 01:22 EST, way under its 52-week high of $55.96 and way above its 52-week low of $16.27.

BanColombia S.A.’s Moving Average

BanColombia S.A.’s value is above its 50-day moving average of $36.60 and way higher than its 200-day moving average of $29.37.

2. InterDigital, Inc.

13.5% sales growth and 6.57% return on equity

InterDigital, Inc. designs and develops technologies that enable and enhance wireless communications in the United States and internationally.

InterDigital, Inc.’s sales growth this year is anticipated to be 11.5% and 0.8% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 370.36M for the twelve trailing months.

InterDigital, Inc.’s sales growth for the next quarter is 13.5%. The company’s growth estimates for the present quarter and the next is a negative 52.3% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.

Volatility

InterDigital, Inc.’s last day, last week, and last month’s average volatility was a negative 0.26%, a negative 0.36%, and a positive 0.04%, respectively.

InterDigital, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.09%, 1.66%, and 1.85%, respectively.

InterDigital, Inc.’s Stock Yearly Top and Bottom Value

InterDigital, Inc.’s stock is valued at $60.68 at 01:22 EST, below its 52-week high of $67.06 and way higher than its 52-week low of $31.04.

InterDigital, Inc.’s Moving Average

InterDigital, Inc.’s worth is under its 50-day moving average of $61.07 and above its 200-day moving average of $59.58.

3. Qorvo, Inc.

19.2% sales growth and 10.28% return on equity

Qorvo, Inc. develops and commercializes technologies and products for wireless and wired connectivity worldwide.

Qorvo, Inc.’s sales growth this year is anticipated to be 18.5% and 9.8% for next year.

Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 3.5B for the twelve trailing months.

Qorvo, Inc.’s sales growth is a negative 0% for the present quarter and 19.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 43% and 26.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.28%.

Volatility

Qorvo, Inc.’s last day, last week, and last month’s average volatility was a negative 0.66%, a positive 0.15%, and a positive 0.19%, respectively.

Qorvo, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.96%, 2.17%, and 2.54%, respectively.

Qorvo, Inc.’s Stock Yearly Top and Bottom Value

Qorvo, Inc.’s stock is valued at $166.27 at 01:22 EST, below its 52-week high of $170.90 and way above its 52-week low of $67.54.

Qorvo, Inc.’s Moving Average

Qorvo, Inc.’s value is higher than its 50-day moving average of $157.81 and way above its 200-day moving average of $133.60.

4. Installed Building Products, Inc.

14.7% sales growth and 33.33% return on equity

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.

Installed Building Products, Inc.’s sales growth this year is anticipated to be 9.7% and 15.4% for next year.

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 1.61B for the twelve trailing months.

Installed Building Products, Inc.’s sales growth for the next quarter is 14.7%. The company’s growth estimates for the present quarter and the next is 33.7% and 39.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.33%.

Volatility

Installed Building Products, Inc.’s last day, last week, and last month’s average volatility was a negative 5.91%, a positive 0.89%, and a positive 0.68%, respectively.

Installed Building Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.95%, 5.35%, and 4.00%, respectively.

Installed Building Products, Inc.’s Stock Yearly Top and Bottom Value

Installed Building Products, Inc.’s stock is valued at $106.59 at 01:22 EST, way below its 52-week high of $121.67 and way higher than its 52-week low of $29.02.

Installed Building Products, Inc.’s Moving Average

Installed Building Products, Inc.’s value is higher than its 50-day moving average of $101.38 and way higher than its 200-day moving average of $93.00.

5. Medpace Holdings, Inc.

11.3% sales growth and 16.76% return on equity

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide.

Medpace Holdings, Inc.’s sales growth this year is anticipated to be 6% and 20.6% for next year.

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 896.13M for the twelve trailing months.

Medpace Holdings, Inc.’s sales growth for the next quarter is 11.3%. The company’s growth estimates for the current quarter and the next is 45.9% and 26.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.76%.

Volatility

Medpace Holdings, Inc.’s last day, last week, and last month’s average volatility was a negative 3.56%, a negative 0.70%, and a positive 0.17%, respectively.

Medpace Holdings, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 5.33%, 3.15%, and 3.15%, respectively.

Medpace Holdings, Inc.’s Stock Yearly Top and Bottom Value

Medpace Holdings, Inc.’s stock is valued at $134.42 at 01:22 EST, way below its 52-week high of $150.57 and way higher than its 52-week low of $58.72.

Medpace Holdings, Inc.’s Moving Average

Medpace Holdings, Inc.’s worth is higher than its 50-day moving average of $134.27 and way higher than its 200-day moving average of $119.10.

LEAVE A REPLY

Please enter your comment!
Please enter your name here